This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.
Participants are adult patients (aged 18 years or older)
Diagnosed with lung, colorectal, breast, or prostate cancer
Are currently receiving active cancer treatments
Are self-managing one or more prescribed cancer medications
Can't access technology or do not use technology
Do not have access to the internet
Do not speak or read English
Not permitted to participate by their health care providers
Single group
Educational Intervention
Other interventionReceive educational materials and resources
Electronic Health Record Review
Other interventionAncillary studies
Follow-Up
Procedure/SurgeryReceive follow-up contact
Internet-Based Intervention
Other interventionUse self-monitoring platform
Interview
Other interventionAncillary studies
Survey Administration
Other interventionAncillary studies
Self-reported system usability
Self-reported system usability will be assessed using the 10-item System Usability Scale. Will use descriptive statistics, such as mean and standard deviation for continuous variables, and frequency and percentage for categorical variables.
Perceived usefulness
Qualitative data, including brief interview data will be analyzed and summarized through content analysis.
Ease of use
Qualitative data, including brief interview data will be analyzed and summarized through content analysis.
Attitudes toward use
Qualitative data, including brief interview data will be analyzed and summarized through content analysis.
Self-tracked, structured medication safety events or concerns
To understand the nature and causes of events and concerns, self-tracked, structured medication safety events or concerns tracking data from the system, such as the number and types of events or concerns self-tracked, will be summarized using descriptive statistics. The free-text tracking data from the system will be analyzed and summarized through content analysis or natural language processing techniques, depending on data volume.
Click on the lead sponsor to view all of their trials.
University of Michigan Rogel Cancer Center
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
